Treatment Action Group

New TAG report: Funding for TB research climbed to new high in 2017

Global funding for TB research climbed to a previously unreported high of USD $772 million in 2017.

Read More →

Checklist of essential TB services

A new checklist from Treatment Action Group lays out simply the core elements of an adequate TB response.

Read More →

Reality Check: The Price of Bedaquiline

The "Reality Check" dispels myths that have been circulated among members of the global TB community and used to justify pricing bedaquiline out of the reach of TB programs and patients.

Read More →

An Activist’s Guide to Bedaquiline (Sirturo)

The guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward.

Read More →

Activists: Call on your countries to use bedaquiline-based regimens to treat TB

The Global Coalition of TB Activists (GCTA), Treatment Action Group (TAG) and the DR-TB Scale-Up Treatment Action Team (DR-TB STAT) developed a letter template to help activists call for bedaquiline-based, injectable-free regimens for the treatment of drug-resistant TB in their countries.

Read More →

New TAG data shows funding for TB research rose in 2017

A new brief from Treatment Action Group shows that global funding for TB research reached a new high of USD $767.8 million in 2017.

Read More →

TAG consultant opportunity: TB Project Consultant

Treatment Action Group (TAG) seeks a consultant to work with its TB team on two grant-specific projects.

Read More →

Webinar on implementing an injectable-free regimen for drug-resistant TB - materials now available online

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB), the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) and TB Proof hosted a webinar on 16 August 2018 on implementing an injectable-free regimen for drug-resistant TB.

Read More →

The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB

The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.

Read More →

Webinar: Implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) will host a webinar on 16 August 2018 at 10 am EDT / 4 pm South Africa / 5 pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB (DR-TB) in light of the new World Health Organization (WHO) policy brief on DR-TB regimens.

Read More →

Page 1 of 12 · Total posts: 10

1 2 Last→